Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.

Aubert O, Higgins S, Bouatou Y, Yoo D, Raynaud M, Viglietti D, Rabant M, Hidalgo L, Glotz D, Legendre C, Delahousse M, Shah N, Sis B, Campbell P, Mengel M, Jouven X, Duong Van Huyen JP, Lefaucheur C, Loupy A.

J Am Soc Nephrol. 2019 Mar 14. pii: ASN.2018070777. doi: 10.1681/ASN.2018070777. [Epub ahead of print]

PMID:
30872323
2.

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M.

Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.

3.

Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection.

Afzali B, Chapman E, Racapé M, Adam B, Bruneval P, Gil F, Kim D, Hidalgo L, Campbell P, Sis B, Duong Van Huyen JP, Mengel M.

Am J Transplant. 2017 Feb;17(2):496-505. doi: 10.1111/ajt.13956. Epub 2016 Aug 2.

4.

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

Demetris AJ, Bellamy C, Hübscher SG, O'Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ, Del Bello A, Reinholt FP, Haga H, Adeyi O, Czaja AJ, Schiano T, Fiel MI, Smith ML, Sebagh M, Tanigawa RY, Yilmaz F, Alexander G, Baiocchi L, Balasubramanian M, Batal I, Bhan AK, Bucuvalas J, Cerski CTS, Charlotte F, de Vera ME, ElMonayeri M, Fontes P, Furth EE, Gouw ASH, Hafezi-Bakhtiari S, Hart J, Honsova E, Ismail W, Itoh T, Jhala NC, Khettry U, Klintmalm GB, Knechtle S, Koshiba T, Kozlowski T, Lassman CR, Lerut J, Levitsky J, Licini L, Liotta R, Mazariegos G, Minervini MI, Misdraji J, Mohanakumar T, Mölne J, Nasser I, Neuberger J, O'Neil M, Pappo O, Petrovic L, Ruiz P, Sağol Ö, Sanchez Fueyo A, Sasatomi E, Shaked A, Shiller M, Shimizu T, Sis B, Sonzogni A, Stevenson HL, Thung SN, Tisone G, Tsamandas AC, Wernerson A, Wu T, Zeevi A, Zen Y.

Am J Transplant. 2016 Oct;16(10):2816-2835. doi: 10.1111/ajt.13909. Epub 2016 Jul 14.

5.

Antibody-Mediated Rejection in a Blood Group A-Transgenic Mouse Model of ABO-Incompatible Heart Transplantation.

Motyka B, Fisicaro N, Wang SI, Kratochvil A, Labonte K, Tao K, Pearcey J, Marshall T, Mengel M, Sis B, Fan X, dʼApice AJ, Cowan PJ, West LJ.

Transplantation. 2016 Jun;100(6):1228-37. doi: 10.1097/TP.0000000000001172.

PMID:
27120451
6.

Nephrology Crossword: Innovative renal pathology for precision diagnosis.

Tompkins JB, Sis B.

Kidney Int. 2016 Jan;89(1):251-2. doi: 10.1016/j.kint.2015.11.002. No abstract available.

PMID:
26759052
7.

Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue.

Adam B, Afzali B, Dominy KM, Chapman E, Gill R, Hidalgo LG, Roufosse C, Sis B, Mengel M.

Clin Transplant. 2016 Mar;30(3):295-305. doi: 10.1111/ctr.12689. Epub 2016 Feb 3.

PMID:
26729350
8.

Isolated endarteritis and kidney transplant survival: a multicenter collaborative study.

Sis B, Bagnasco SM, Cornell LD, Randhawa P, Haas M, Lategan B, Magil AB, Herzenberg AM, Gibson IW, Kuperman M, Sasaki K, Kraus ES; Banff Working Group.

J Am Soc Nephrol. 2015 May;26(5):1216-27. doi: 10.1681/ASN.2014020157. Epub 2014 Nov 7.

9.

Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease.

Sharon D, Chen M, Zhang G, Girgis S, Sis B, Graham D, McDougall C, Wasilenko ST, Montano-Loza A, Mason AL.

Liver Int. 2015 Apr;35(4):1442-50. doi: 10.1111/liv.12699. Epub 2014 Oct 31.

10.

A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection.

Sapir-Pichhadze R, Curran SP, John R, Tricco AC, Uleryk E, Laupacis A, Tinckam K, Sis B, Beyene J, Logan AG, Kim SJ.

Kidney Int. 2015 Jan;87(1):182-94. doi: 10.1038/ki.2014.166. Epub 2014 May 14. Review.

11.

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee.

Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590. Erratum in: Am J Transplant. 2015 Oct;15(10):2784. Rangel, Erika [corrected to Rangel, Erika B].

12.

VSL#3 probiotics provide protection against acute intestinal ischaemia/reperfusion injury.

Salim SY, Young PY, Lukowski CM, Madsen KL, Sis B, Churchill TA, Khadaroo RG.

Benef Microbes. 2013 Dec 1;4(4):357-65. doi: 10.3920/BM2013.0026.

PMID:
24240573
13.

Intragraft donor-specific antibody detection: a new test to dichotomize HLA alloantibodies into high and low injurious activity.

Sis B.

Am J Transplant. 2013 Nov;13(11):2787-9. doi: 10.1111/ajt.12440. Epub 2013 Sep 18. No abstract available.

14.

Pathologic basis of antibody-mediated organ transplant rejection: from pathogenesis to diagnosis.

Joudeh A, Saliba KA, Topping KA, Sis B.

Curr Opin Organ Transplant. 2013 Aug;18(4):478-85. doi: 10.1097/MOT.0b013e3283636ce6. Review.

PMID:
23838653
15.

An unusual cause of elevated liver enzymes in a diabetic patient.

Al-Judaibi B, Bain VG, Sis B.

Gastroenterology. 2013 Jun;144(7):1354, 1577-8. doi: 10.1053/j.gastro.2013.01.061. Epub 2013 Apr 26. No abstract available.

PMID:
23623878
16.

Diagnostic criteria for kidney transplant rejection: a call to action.

Bagnasco S, Kraus E, Sis B.

Lancet. 2013 Apr 27;381(9876):1458. doi: 10.1016/S0140-6736(13)60923-X. No abstract available.

PMID:
23622280
17.

Molecular transplantation pathology: the interface between molecules and histopathology.

Hsu YH, Sis B.

Curr Opin Organ Transplant. 2013 Jun;18(3):354-62. doi: 10.1097/MOT.0b013e3283614c90. Review.

PMID:
23619514
18.

Molecular diagnosis of antibody-mediated rejection in human kidney transplants.

Sellarés J, Reeve J, Loupy A, Mengel M, Sis B, Skene A, de Freitas DG, Kreepala C, Hidalgo LG, Famulski KS, Halloran PF.

Am J Transplant. 2013 Apr;13(4):971-983. doi: 10.1111/ajt.12150. Epub 2013 Feb 15.

19.

Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies.

Reeve J, Sellarés J, Mengel M, Sis B, Skene A, Hidalgo L, de Freitas DG, Famulski KS, Halloran PF.

Am J Transplant. 2013 Mar;13(3):645-55. doi: 10.1111/ajt.12079. Epub 2013 Jan 28.

20.

Advances in the understanding of transplant glomerulopathy.

Husain S, Sis B.

Am J Kidney Dis. 2013 Aug;62(2):352-63. doi: 10.1053/j.ajkd.2012.10.026. Epub 2013 Jan 11. Review.

PMID:
23313456
21.

Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection.

Sis B.

Hum Immunol. 2012 Dec;73(12):1218-25. doi: 10.1016/j.humimm.2012.07.332. Epub 2012 Jul 31. Review.

PMID:
22863448
22.

Phenotypes of antibody-mediated rejection in organ transplants.

Mengel M, Husain S, Hidalgo L, Sis B.

Transpl Int. 2012 Jun;25(6):611-22. doi: 10.1111/j.1432-2277.2012.01484.x. Epub 2012 Apr 25. Review.

23.

Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies.

Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF.

Am J Transplant. 2012 May;12(5):1180-91. doi: 10.1111/j.1600-6143.2011.03970.x. Epub 2012 Mar 5.

24.

Molecular phenotypes of acute kidney injury in kidney transplants.

Famulski KS, de Freitas DG, Kreepala C, Chang J, Sellares J, Sis B, Einecke G, Mengel M, Reeve J, Halloran PF.

J Am Soc Nephrol. 2012 May;23(5):948-58. doi: 10.1681/ASN.2011090887. Epub 2012 Feb 16.

25.

A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.

Sis B, Jhangri GS, Riopel J, Chang J, de Freitas DG, Hidalgo L, Mengel M, Matas A, Halloran PF.

Am J Transplant. 2012 May;12(5):1168-79. doi: 10.1111/j.1600-6143.2011.03931.x. Epub 2012 Feb 2.

26.

Banff 2011 Meeting report: new concepts in antibody-mediated rejection.

Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Cendales L, Demetris AJ, Drachenberg CB, Farver CF, Rodriguez ER, Wallace WD, Glotz D; Banff meeting report writing committee.

Am J Transplant. 2012 Mar;12(3):563-70. doi: 10.1111/j.1600-6143.2011.03926.x. Epub 2012 Feb 2.

27.

Pros and cons for C4d as a biomarker.

Cohen D, Colvin RB, Daha MR, Drachenberg CB, Haas M, Nickeleit V, Salmon JE, Sis B, Zhao MH, Bruijn JA, Bajema IM.

Kidney Int. 2012 Apr;81(7):628-39. doi: 10.1038/ki.2011.497. Epub 2012 Feb 1. Review.

28.

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.

Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF.

Am J Transplant. 2012 Feb;12(2):388-99. doi: 10.1111/j.1600-6143.2011.03840.x. Epub 2011 Nov 14.

29.

The nature of biopsies with "borderline rejection" and prospects for eliminating this category.

de Freitas DG, Sellarés J, Mengel M, Chang J, Hidalgo LG, Famulski KS, Sis B, Einecke G, Halloran PF.

Am J Transplant. 2012 Jan;12(1):191-201. doi: 10.1111/j.1600-6143.2011.03784.x. Epub 2011 Oct 12.

30.

Superiority of virtual microscopy versus light microscopy in transplantation pathology.

Ozluk Y, Blanco PL, Mengel M, Solez K, Halloran PF, Sis B.

Clin Transplant. 2012 Mar-Apr;26(2):336-44. doi: 10.1111/j.1399-0012.2011.01506.x. Epub 2011 Sep 29.

PMID:
21955102
31.

Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases.

Sellarés J, de Freitas DG, Mengel M, Sis B, Hidalgo LG, Matas AJ, Kaplan B, Halloran PF.

Am J Transplant. 2011 Mar;11(3):489-99. doi: 10.1111/j.1600-6143.2010.03415.x.

32.

Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome.

Morgan C, Sis B, Pinsk M, Yiu V.

Nephrol Dial Transplant. 2011 Sep;26(9):2860-5. doi: 10.1093/ndt/gfq813. Epub 2011 Feb 8.

PMID:
21303962
33.

The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course.

Mengel M, Chang J, Kayser D, Gwinner W, Schwarz A, Einecke G, Broecker V, Famulski K, de Freitas DG, Guembes-Hidalgo L, Sis B, Haller H, Halloran PF.

Am J Transplant. 2011 Apr;11(4):708-18. doi: 10.1111/j.1600-6143.2010.03339.x. Epub 2010 Nov 29.

34.

An integrated view of molecular changes, histopathology and outcomes in kidney transplants.

Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, MengeL M, Reeve J, Sellares J, Sis B.

Am J Transplant. 2010 Oct;10(10):2223-30.

PMID:
20931696
35.

The molecular phenotype of kidney transplants.

Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, Mengel M, Reeve J, Sellares J, Sis B.

Am J Transplant. 2010 Oct;10(10):2215-22.

PMID:
20931695
36.

Loss of solute carriers in T cell-mediated rejection in mouse and human kidneys: an active epithelial injury-repair response.

Einecke G, Kayser D, Vanslambrouck JM, Sis B, Reeve J, Mengel M, Famulski KS, Bailey CG, Rasko JE, Halloran PF.

Am J Transplant. 2010 Oct;10(10):2241-51. doi: 10.1111/j.1600-6143.2010.03263.x.

37.

The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables.

Mengel M, Sis B, Kim D, Chang J, Famulski KS, Hidalgo LG, Einecke G, de Freitas DG, Tymchak W, Burton J, Halloran PF.

Am J Transplant. 2010 Sep;10(9):2105-15. doi: 10.1111/j.1600-6143.2010.03182.x.

38.

NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.

Hidalgo LG, Sis B, Sellares J, Campbell PM, Mengel M, Einecke G, Chang J, Halloran PF.

Am J Transplant. 2010 Aug;10(8):1812-22. doi: 10.1111/j.1600-6143.2010.03201.x.

39.

A molecular classifier for predicting future graft loss in late kidney transplant biopsies.

Einecke G, Reeve J, Sis B, Mengel M, Hidalgo L, Famulski KS, Matas A, Kasiske B, Kaplan B, Halloran PF.

J Clin Invest. 2010 Jun;120(6):1862-72. doi: 10.1172/JCI41789. Epub 2010 May 24.

40.

Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.

Douglas DN, Kawahara T, Sis B, Bond D, Fischer KP, Tyrrell DL, Lewis JT, Kneteman NM.

PLoS One. 2010 Feb 18;5(2):e9209. doi: 10.1371/journal.pone.0009209.

41.

Defining the canonical form of T-cell-mediated rejection in human kidney transplants.

Famulski KS, Einecke G, Sis B, Mengel M, Hidalgo LG, Kaplan B, Halloran PF.

Am J Transplant. 2010 Apr;10(4):810-20. doi: 10.1111/j.1600-6143.2009.03007.x. Epub 2010 Feb 3.

42.

Alternative macrophage activation-associated transcripts in T-cell-mediated rejection of mouse kidney allografts.

Famulski KS, Kayser D, Einecke G, Allanach K, Badr D, Venner J, Sis B, Halloran PF.

Am J Transplant. 2010 Mar;10(3):490-7. doi: 10.1111/j.1600-6143.2009.02983.x. Epub 2010 Jan 29.

43.

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary A, Zeevi A.

Am J Transplant. 2010 Mar;10(3):464-71. doi: 10.1111/j.1600-6143.2009.02987.x. Epub 2010 Jan 29.

44.

Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring.

Sis B, Einecke G, Chang J, Hidalgo LG, Mengel M, Kaplan B, Halloran PF.

Am J Transplant. 2010 Feb;10(2):421-30. doi: 10.1111/j.1600-6143.2009.02938.x. Epub 2010 Jan 6.

45.

Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.

Sis B, Halloran PF.

Curr Opin Organ Transplant. 2010 Feb;15(1):42-8. doi: 10.1097/MOT.0b013e3283352a50. Review.

PMID:
20009933
46.

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure.

Hidalgo LG, Campbell PM, Sis B, Einecke G, Mengel M, Chang J, Sellares J, Reeve J, Halloran PF.

Am J Transplant. 2009 Nov;9(11):2532-41. doi: 10.1111/j.1600-6143.2009.02800.x.

47.

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.

Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF.

Am J Transplant. 2009 Nov;9(11):2520-31. doi: 10.1111/j.1600-6143.2009.02799.x.

48.

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF.

Am J Transplant. 2009 Oct;9(10):2312-23. doi: 10.1111/j.1600-6143.2009.02761.x. Epub 2009 Jul 22.

49.

Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts.

Mengel M, Reeve J, Bunnag S, Einecke G, Jhangri GS, Sis B, Famulski K, Guembes-Hidalgo L, Halloran PF.

Am J Transplant. 2009 Aug;9(8):1859-67. doi: 10.1111/j.1600-6143.2009.02727.x. Epub 2009 Jun 26.

50.

Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches.

Reeve J, Einecke G, Mengel M, Sis B, Kayser N, Kaplan B, Halloran PF.

Am J Transplant. 2009 Aug;9(8):1802-10. doi: 10.1111/j.1600-6143.2009.02694.x. Epub 2009 Jun 10.

Supplemental Content

Support Center